Catalio Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001958125

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 46 positions · Total reported value $535.82M · Top-10 concentration 48.7% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.5% · 13 new · 14 cut · 6 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, Catalio Capital Management, LP disclosed 46 equity positions with a combined reported value of $535.82M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were AVLN ($48.40M), BMY ($31.18M), BBIO ($27.97M). By sector, the heaviest allocations are Health Care 96.3%, Industrials 2.8%. Versus the prior quarter, allocation shifted toward Industrials (+2.8pp) and away from Other (-0.7pp), Health Care (-2.0pp).

Versus the prior quarter, Catalio Capital Management, LP opened 13 new positions, trimmed 14 and fully exited 6, a turnover rate of 63.5% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q3 2026 were ARWR ($20.63M), CELC ($18.34M), GH ($16.51M).

Of the 6 positions fully exited versus the prior quarter, the largest were GILD ($34.02M), INCY ($21.72M), AXSM ($10.57M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARWR ARROWHEAD PHARMACEUTICALS IN · $20.63M
  • CELC CELCUITY INC · $18.34M
  • GH GUARDANT HEALTH INC · $16.51M
  • TXG 10X GENOMICS INC · $14.82M
  • AMLX AMYLYX PHARMACEUTICALS INC · $14.72M
  • ENTX ENTERA BIO LTD · $11.41M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $8.70M
  • ANNX ANNEXON INC · $8.40M

Fully Exited (vs previous quarter)

  • GILD GILEAD SCIENCES INC · prev qtr: $34.02M
  • INCY INCYTE CORP · prev qtr: $21.72M
  • AXSM AXSOME THERAPEUTICS INC. · prev qtr: $10.57M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $5.44M
  • DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $3.21M
  • ATAI ATAI LIFE SCIENCES NV · prev qtr: $1.04M

Insider Transactions (Form 4)

Latest Catalio Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 742,546 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,458,290 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,995,749 — SEC filing

All insider transactions →

Fund Profile

Catalio Capital Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 46 US equity positions with a combined value of $535.82M. HoldingsHub carries 8 quarters of its filings (Q4 2024–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121976 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $1.93B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 78%, pooled investment vehicles 13%
  • Manages 23 private funds, of which 1 hedge funds

Portfolio Structure

  • 46 positions · $535.82M reported value (Q3 2026)
  • Top 10 holdings = 48.7% of reported value
  • Largest position: AVLN (AVALYN PHARMACEUTICALS INC) at 9.0%
  • Average position size: $11.65M

Sector Tilt

  • Health Care 96.3%
  • Industrials 2.8%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 13 new, 13 added, 14 reduced, 6 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 96.3%
Other 0.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.70M $48.40M 9.03%
9.03%
Add
2 499.72K $31.18M 5.82%
5.82%
Add
3 425.11K $27.97M 5.22%
5.22%
Reduce
4 824.04K $26.61M 4.97%
4.97%
Hold
5 99.50K $26.34M 4.92%
4.92%
Reduce
6 101.44K $23.11M 4.31%
4.31%
Add
7 315.25K $20.63M 3.85%
3.85%
New
8 1.02M $19.24M 3.59%
3.59%
Reduce
9 497.96K $18.95M 3.54%
3.54%
Reduce
10 230.61K $18.34M 3.42%
3.42%
New
11 454.01K $17.77M 3.32%
3.32%
Reduce
12 92.58K $16.51M 3.08%
3.08%
New
13 112.42K $15.84M 2.96%
2.96%
Add
14 164.03K $14.82M 2.77%
2.77%
New
15 505.88K $14.72M 2.75%
2.75%
New
16 583.36K $14.66M 2.74%
2.74%
Reduce
17 161.12K $13.91M 2.60%
2.60%
Add
18 1.02M $11.77M 2.20%
2.20%
Reduce
19 95.65K $11.60M 2.16%
2.16%
Add
20 3.92M $11.41M 2.13%
2.13%
New
21 172.71K $11.31M 2.11%
2.11%
Add
22 457.84K $10.17M 1.90%
1.90%
Hold
23 684.75K $9.80M 1.83%
1.83%
Add
24 601.76K $9.04M 1.69%
1.69%
Add
25 144.97K $8.70M 1.62%
1.62%
New
26 1.99M $8.40M 1.57%
1.57%
New
27 85.61K $8.15M 1.52%
1.52%
New
28 260.11K $8.13M 1.52%
1.52%
Reduce
29 126.82K $7.68M 1.43%
1.43%
New
30 211.99K $6.42M 1.20%
1.20%
Add
31 167.72K $5.37M 1.00%
1.00%
New
32 468.75K $5.35M 1.00%
1.00%
Hold
33 12.53K $5.18M 0.97%
0.97%
Reduce
34 8.84M $4.81M 0.90%
0.90%
Add
35 312.50K $4.61M 0.86%
0.86%
Hold
36 1.64M $4.14M 0.77%
0.77%
Reduce
37 74.97K $3.73M 0.70%
0.70%
Reduce
38 699.53K $2.87M 0.54%
0.54%
Add
39 87.70K $2.81M 0.52%
0.52%
New
40 512.29K $1.56M 0.29%
0.29%
Reduce
41 976.19K $1.19M 0.22%
0.22%
Add
42 1.30M $1.05M 0.20%
0.20%
Reduce
43 528.99K $560.73K 0.10%
0.10%
Hold
44 14.72K $437.71K 0.08%
0.08%
Hold
45 107.46K $322.37K 0.06%
0.06%
Reduce
46 11.36K $226.46K 0.04%
0.04%
New

FAQ

What did Catalio Capital Management, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Catalio Capital Management, LP reported 46 equity positions worth $535.82M in aggregate; its largest disclosed positions were AVLN ($48.40M), BMY ($31.18M), BBIO ($27.97M).

How large is Catalio Capital Management, LP's portfolio?

Catalio Capital Management, LP reported $535.82M of long equity holdings across 46 positions as of 2026-Q3. Top-10 holdings account for 48.7% of reported value.

What is Catalio Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/catalio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →